Topotecan for relapsed small cell lung cancer: retrospective study

被引：0
|
作者：
Alegria, Ana M. [1 ]
Rodrigues, Cidalia [2 ]
Teixeira, Encarnacao [1 ]
Barata, Fernando [2 ]
Sotto-Mayor, Renato [1 ]
Figueiredo, Ana [2 ]
Rito, Emilia [1 ]
Almeida, Antonio B. [1 ]
机构：
[1] Hosp Santa Maria, Lisbon, Portugal
[2] Ctr Hosp Coimbra, Coimbra, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S805 / S805
页数：1
相关论文
共 50 条
  • [21] Late phase II trials of topotecan (T) for relapsed small cell lung cancer (SCLC)
    Nishiwaki, Y
    Negoro, S
    Watanabe, K
    Fukuoka, M
    Niitani, H
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S253 - S253
  • [22] A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
    Agelaki, S.
    Kontopodis, E.
    Kotsakis, A.
    Chandrinos, V.
    Bompolaki, I.
    Zafeiriou, Z.
    Papadimitraki, E.
    Stoltidis, D.
    Kalbakis, K.
    Georgoulias, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 45 - 51
  • [23] A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
    Imai, Hisao
    Sugiyama, Tomohide
    Tamura, Tomohiro
    Minemura, Hiroyuki
    Kaira, Kyoichi
    Kanazawa, Kenya
    Yokouchi, Hiroshi
    Kasai, Takashi
    Kaburagi, Takayuki
    Minato, Koichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 615 - 622
  • [24] A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
    Hisao Imai
    Tomohide Sugiyama
    Tomohiro Tamura
    Hiroyuki Minemura
    Kyoichi Kaira
    Kenya Kanazawa
    Hiroshi Yokouchi
    Takashi Kasai
    Takayuki Kaburagi
    Koichi Minato
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 615 - 622
  • [25] Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study
    Nakamichi, Shinji
    Kubota, Kaoru
    Zou, Fenfei
    Hayashi, Anna
    Takano, Natsuki
    Onda, Naomi
    Matsumoto, Masaru
    Miyanaga, Akihiko
    Noro, Rintaro
    Seike, Masahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (07) : 872 - 879
  • [26] A Retrospective Study of Amrubicin Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients
    Minemura, H.
    Imai, H.
    Sugiyama, T.
    Tamura, T.
    Kaira, K.
    Kanazawa, K.
    Yokouchi, H.
    Kasai, T.
    Kaburagi, T.
    Minato, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2043 - S2043
  • [27] Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study
    Shinji Nakamichi
    Kaoru Kubota
    Fenfei Zou
    Anna Hayashi
    Natsuki Takano
    Naomi Onda
    Masaru Matsumoto
    Akihiko Miyanaga
    Rintaro Noro
    Masahiro Seike
    International Journal of Clinical Oncology, 2023, 28 : 872 - 879
  • [28] A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
    Sugiyama, T.
    Imai, H.
    Tamura, T.
    Minemura, H.
    Kaira, K.
    Kanazawa, K.
    Yokouchi, H.
    Kasai, T.
    Kaburagi, T.
    Minato, K.
    ANNALS OF ONCOLOGY, 2017, 28 : 153 - 153
  • [29] OUR EXPERIENCE WITH TOPOTECAN AS SECOND-LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2010, 16 (03): : 70 - 73
  • [30] Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease
    Enomoto, Yasunori
    Inui, Naoki
    Imokawa, Shiro
    Karayama, Masato
    Hasegawa, Hirotsugu
    Ozawa, Yuichi
    Matsui, Takashi
    Yokomura, Koshi
    Suda, Takafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 499 - 505
12345